Back to Journals » Biologics: Targets and Therapy » Volume 3

Review

Anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

       
Total article views   HTML views PDF downloads Totals
14,359 Dovepress* 14,359+ 2,591 16,950
Totals 14,359 2,591 16,950
*Since 17 June 2009
+Since July 2016

View citations on Google Scholar